Health and Fitness Health and Fitness
Mon, March 5, 2012
[ Mon, Mar 05th 2012 ] - Market Wire
Sienna Gold Warrants Extended
[ Mon, Mar 05th 2012 ] - Market Wire
30 a.m. ET
Fri, March 2, 2012
Thu, March 1, 2012
Wed, February 29, 2012
Tue, February 28, 2012
[ Tue, Feb 28th 2012 ] - Market Wire
Alere to Acquire eScreen, Inc.
[ Tue, Feb 28th 2012 ] - Market Wire
ICON Acquires PriceSpective
Mon, February 27, 2012
Sat, February 25, 2012
Fri, February 24, 2012
[ Fri, Feb 24th 2012 ] - Market Wire
BrainStorm Featured on CNBC
Thu, February 23, 2012
[ Thu, Feb 23rd 2012 ] - Market Wire
00 am ET
Wed, February 22, 2012
Tue, February 21, 2012
[ Tue, Feb 21st 2012 ] - Market Wire
Black Smoker Corporate Update

Teva to Present at the 2012 RBC Capital Marketsa Global Healthcare Conference


//health-fitness.news-articles.net/content/2012/ .. pital-marketsa-global-healthcare-conference.html
Published in Health and Fitness on Tuesday, February 28th 2012 at 5:39 GMT by Market Wire   Print publication without navigation


JERUSALEM--([ ])--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) will host a live audio webcast at the 2012 RBC Capital Marketsa Global Healthcare Conference in New York. Lesley Russell, SVP, R&D Global Branded Products, will present on Wednesday, February 29, 2012.

What: Teva Presentation at the 2012 RBC Capital Marketsa Global Healthcare Conference
Who: Lesley Russell, SVP, R&D Global Branded Products
When: Wednesday, February 29, 2012 at 8:30 AM (ET)
Where:

[ http://ir.tevapharm.com/phoenix.zhtml?c=73925&p=irol-presentations ] or

[ http://www.wsw.com/webcast/rbc141/teva ]

How: Live over the Internet a" log on to the Web at the address above and register for the event (approximately 10 minutes before).
An archive of the webcast will be available on Tevaas website.

About Teva

Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Headquartered in Israel, Teva is the world's largest generic drug maker, with a global product portfolio of more than 1,300 molecules and a direct presence in about 60 countries. Teva's branded businesses focus on CNS, oncology, pain, respiratory and women's health therapeutic areas as well as biologics. Teva currently employs approximately 46,000 people around the world and reached $18.3 billion in net revenues in 2011.


Publication Contributing Sources